Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

First patient treated in Mapi Pharma's Phase IIa clinical trial of GA Depot for relapsing remitting multiple sclerosis (RRMS)
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
Laquinimod Phase IIa Study in Active Crohn's Disease
UPDATE 1-Teva Pharmaceutical banks on thrice-weekly Copaxone
Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma
Rituximab Use in Pediatric Central Demyelinating Disease.
Neuroprotective effect of masitinib in rats with postischemic stroke.
The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
Company restores access to multiple sclerosis drug after pressure from neurologists.
Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis.
Immunomodulatory effects of Vitamin D in multiple sclerosis.
Laquinimod in multiple sclerosis.
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.
PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms.
BTG Commences Phase IIa Study of Multiple Sclerosis
Takeda Submits a New Drug Application for Glatiramer Acetate in Japan for the Relapse Prevention of Multiple Sclerosis
Dynamic regulatory network controlling TH17 cell differentiation.
Predictive value of early brain atrophy on response in patients treated with interferon β.
FTY720 in patients with primary progressive multiple sclerosis (INFORMS)
IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis.
Genetics of multiple sclerosis: swimming in an ocean of data.
Varicella-Zoster Virus Infections in Patients Treated With Fingolimod: Risk Assessment and Consensus Recommendations for Management.
Idebenone for primary progressive multiple sclerosis
Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY Study.
Role of the Blood-Brain Barrier in Multiple Sclerosis.

Pages